| Date Filed | Type | Description |
| 10/12/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/16/2023 |
SC 13D/A
| Boxer Capital, LLC reports a 15.9% stake in Mirati Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Boxer Capital, LLC reports a 2% stake in Milestone Pharmaceuticals Inc. |
| 02/14/2023 |
SC 13G/A
| Boxer Capital, LLC reports a 4.6% stake in IDEAYA, Inc. |
| 02/14/2023 |
SC 13G/A
| Boxer Capital, LLC reports a 6.9% stake in PMV Pharmaceuticals, Inc. |
| 11/08/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/19/2022 |
SC 13G
| Boxer Capital, LLC reports a 5.7% stake in SpringWorks Therapeutics, Inc. |
| 06/15/2022 |
SC 13D/A
| Boxer Capital, LLC reports a 15.1% stake in Tyra Biosciences, Inc. |
| 05/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 7.5% stake in Milestone Pharmaceuticals Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 7.2% stake in Atreca, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 0% stake in MATINAS BIOPHARMA HOLDINGS, INC. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC has filed a Schedule 13D for Mereo Biopharma Group plc |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 4.7% stake in SOLID BIOSCIENCES INC. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 1.9% stake in Cabaletta Bio, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 1.9% stake in DBV Technologies S.A. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 0% stake in SILVERBACK THERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 0% stake in CYMABAY THERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 3.8% stake in Elevation Oncology, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 0% stake in F-Star Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 2.8% stake in POINT Biopharma Global Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 6.3% stake in PMV Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 0% stake in TALIS BIOMEDICAL CORPORATION |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 4.1% stake in Biomea Fusion, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 4.4% stake in Merus N.V. |
| 11/26/2021 |
SC 13D/A
| Boxer Capital, LLC reports a 10.9% stake in Odonate Therapeutics, Inc. |
| 11/22/2021 |
SC 13D/A
| Boxer Capital, LLC reports a 12% stake in Odonate Therapeutics, Inc. |
| 09/24/2021 |
SC 13D
| Boxer Capital, LLC reports a 14.9% stake in Tyra Biosciences, Inc. |
| 07/09/2021 |
SC 13G
| Boxer Capital, LLC reports a 5.9% stake in Elevation Oncology, Inc. |
| 05/17/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/03/2021 |
SC 13D
| Boxer Capital, LLC reports a 10% stake in Rain Therapeutics Inc. |
| 04/30/2021 |
SC 13G
| Boxer Capital, LLC reports a 7.3% stake in Biomea Fusion, Inc. |
| 02/26/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|